All filters
Slidesets
Hepatitis B screening and prevention integration into ante-natal care and delivery services in an urban cohort in Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Population-based evaluation of hepatitis B markers and criteria for antiviral therapy in Lusaka Province, Zambia- Michael Vinikoor
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Treatment of chronic hepatitis B in sub-Saharan Africa: 3-year results of a pilot program in Ethiopia- Asgeir Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Characterization of Hepatitis B Virus (HBV) Among Liver Patients in Kenya- Missiani Ochwoto
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Prevalence of HBV and HCV infections in screened people in Rwanda during WHD 2017 campaign- Jean Damascene Makuza
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
HCV diagnosis and direct-acting antiviral agents -based treatment for HIV/HCV co-infected patients in a primary care setting in Maputo, Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Ledipasvir/Sofosbuvir for Treatment of Hepatitis C Virus Infection in Rwanda: Results from the SHARED Trial- Emmanuel Musabeyezu
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Viral hepatitis in paediatrics (B and C)- Manal El-Sayed, MD, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Other special populations (PWID)- John Rwegasha, MBChB, M.MED, FRCP, MSc
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Alcoholic liver disease- Kosh Agarwal, MD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Drug-induced liver disease: khat and other weeds- Asgeir Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Parasitic infections (Schistosomiasis infection, Liver flukes)- Edford Sinkala, BScHB, MBChB, MMed, PhD, FRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Fatty Liver disease- Mark Thursz, MRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Point-of-care testing for hepatitis B virus infection in a community-based occupational health cohort in the Western Cape Province, South Africa- Nafiisah Chotun
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Management of Hepatocellular Carcinoma in Africa- Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Large-scale discovery and validation of blood and urinary discriminant metabolites as potential biomarkers for the diagnosis hepatocellular carcinoma in West Africa -Mei Ran Abellona
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Management of end-stage Liver Disease in Resource Limited Settings- Mark Sonderup
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
The establishment of hepatitis B care and treatment clinics in the United Republic of Tanzania: A demonstration project following WHO guidelines- John Rwegasha
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
New diagnostics to improve diagnosis of liver disease- Francesco Marinucci
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
NOhep Visionaries in Africa: Medical professionals leading the way towards hepatitis elimination- Jessica Hicks
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
WHO status report: Global response to the strategic framework- Yvan Hutin, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - Egypt- Imam Waked, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017